Filter by: patients
Home > Community Treatment Reports and Side Effects > Xolair Treatment Report
What is Xolair?

Xolair® is a brand name for the drug omalizumab, an antiastmatic medication used in the treatment of moderate-to-severe, persistent allergic asthma not adequately controlled with inhaled corticosteroids.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Asthma 2 1 Efficacy_major
Asthma 1 0

See all 4 patients currently taking Xolair

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 1

Reported Dosages

  2 monthly 150 mg monthly 450 mg every other week
  1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Xolair (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 1   Other: 100%

See all 1 patient who’ve stopped taking Xolair

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Xolair

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Xolair

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Xolair

Always
 1 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Xolair

Very
 0 0%
Somewhat
 1 100%
A little
 0 0%
Not at all
 0 0%

Cost

Paid out of pocket

Cost of Xolair

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 1 100%
< $25
 0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.